Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
作者信息
Zittoun R, Mandelli F, Willemze R, de Witte T, Tura S, Ferrini P R, Stryckmans P, Gattringer C, Petti M C, Solbu G